Oct 11 (Reuters) – The U.S. Food and Drug Administration on
Tuesday said it has determined the widely-used blood thinner
Xarelto to be safe and effective for patients with the heart
condition atrial…
The post U.S. FDA clears Xarelto blood thinner despite faulty trial device appeared first on NASDAQ.